Medical Device | April 14, 2026
AKM and Kyoto University break ground with 2 µm PCSEL laser
Paves the way for next-gen ultra-precise gas sensing
Paves the way for next-gen ultra-precise gas sensing
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Biopharma companies face persistent hurdles in cell line development, including long timelines, low yields, and high failure rates for novel molecules
Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies
Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Safety was equally impressive. ENV-294 was well tolerated
Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.
Subscribe To Our Newsletter & Stay Updated
